Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 known ✓ | P30542 | 3/20 | 0.89 |
| ▸ | ADORA3 known ✓ | P0DMS8 | 3/20 | 0.89 |
| ▸ | ADORA2A known ✓ | P29274 | 1/20 | 0.89 |
| ▸ | ADORA2B known ✓ | P29275 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.89 |
| ▸ | DPP4 | P27487 | 1/20 | 0.89 |
| ▸ | MEN1 | O00255 | 1/20 | 0.89 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.89 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.89 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.89 |
| ▸ | GAPDH | P04406 | 1/20 | 0.89 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.89 |
| ▸ | STAT6 | P42226 | 1/20 | 0.89 |
| ▸ | PI4KA | P42356 | 1/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.89 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.89 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.89 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.89 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.89 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine SCHEMBL6242700 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL9171507 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL3046213 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL459769 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL3031964 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL1746637 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL468212 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL1744578 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Vidarabine SCHEMBL7103173 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 | |
| Adenosine SCHEMBL9147194 | 1.00 | ADORA1 (0.89) | ADORA1SMN1; SMN2ADORA3DPP4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17365 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144821-A1 | Treatment of Blood Transfusion-Dependent Patients with Hematologic Malignancies | HEMANEXT INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-20260144822-A1 | Treatment of Burn Patients with Hypoxic Blood | HEMANEXT INC. (US) | 2026-05-28 | — | — | US | claimed |
| CN-122075514-A | Use of glycogen phosphatase B agonists for the treatment of neurodegenerative diseases | — | 2026-05-26 | — | — | CN | claimed |
| CN-122072262-A | Detection method and kit for absolute quantification of multiple neurotransmitters and related metabolites | 清华大学 | 2026-05-22 | — | — | CN | claimed |
| WO-2026102307-A1 | ACELLULAR BLOOD ALTERNATIVE FOR TRANSFUSION AND ORGAN PERFUSION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-15 | — | — | WO | claimed |
| EP-4741012-A2 | COMPOSITIONS AND METHODS FOR REDUCING AMYLOID BETA FORMATION AND COMPOSITION THEREFORE | Aribio Co., Ltd. (KR) | 2026-05-13 | — | — | EP | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20260125717-A1 | Bioreactor and Process for Forming Polyhydroxybutyrate Directly from Depolymerized Polyhydroxybutyrate | KIMBERLY CLARK CO (US) | 2026-05-07 | — | — | US | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026085618-A1 | METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION | YYZ PHARMATECH INC. (CA) | 2026-04-30 | — | — | WO | claimed |
| US-4277562-A | Stabilized liquid enzyme and coenzyme compositions | MEDICAL ANALYSIS SYSTEMS, INC. | 1981-07-07 | — | — | US | claimed |
| US-4271264-A | Stabilized liquid enzyme and coenzyme compositions | MEDICAL ANALYSIS SYSTEMS, INC. | 1981-06-02 | — | — | US | claimed |
| US-4250254-A | USING AN AQUEOUS VEHICLE, A MISCIBLE POLYOL SOLVENT, AND A POLYMER; PH; SHELF LIFE; MEDICAL DIAGNOSIS | MEDICAL ANALYSIS SYSTEMS, INC. | 1981-02-10 | — | — | US | claimed |
| US-4209316-A | NUCLEOSIDES OR NUCLEOTIDES WITH A BUFFER | UNIVERSITY PATENTS, INC. (US) | 1980-06-24 | — | — | US | claimed |
| US-4199498-A | Macromolecularized adenine derivatives | SNAMPROGETTI S.P.A. (IT) | 1980-04-22 | — | — | US | claimed |
| EP-0006582-A2 | Method for stabilizing solutions of gamma-glutamyl-p-nitroanilide | Modrovich, Ivan Endre (US) | 1980-01-09 | — | — | EP | claimed |
| US-4164444-A | Method for preparing adenosine triphosphate | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1979-08-14 | — | — | US | claimed |
| US-4071413-A | Method for determining free fatty acids in blood serum using fatty acid activating enzymes | ONO PHARMACEUTICAL CO., LTD. (JA) | 1978-01-31 | — | — | US | claimed |
| US-4061828-A | Modified, grafted mineral carriers | RHONE-POULENC INDUSTRIES (FR) | 1977-12-06 | — | — | US | claimed |
| US-4017597-A | STORAGE STABILITY, MEDICAL DIAGNOSIS | MONSANTO COMPANY (US) | 1977-04-12 | — | — | US | claimed |